Universal Health Realty Income Trust

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service related facilities including acute care hospitals, rehabilitation hospitals, sub-acute care facilities, medical/office buildings, free-standing emergency departments and childcare centers. We have investments in seventy-one properties located in twenty states, including two that are currently under construction.

Universal Health Realty Income Trust trades as UHT on NYSE. The company is classified in Real Estate / REIT - Healthcare Facilities and reports in USD.

The current profile places the business in REIT - Healthcare Facilities. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Universal Health Realty Income Trust can be compared against peers such as Adamas Trust, Inc., Armada Hoffler Properties, Inc., Saul Centers, Inc., CTO Realty Growth, Inc., Gladstone Commercial Corporation, Invesco Mortgage Capital Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $571.67M, beta of 0.86, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

UHT currently shows total debt of $386.03M and beta of 0.86. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: 4 (2026-06-05 00:00:00), 10-Q (2026-05-07 00:00:00), SC 13G (2026-04-29 00:00:00), DEFA14A (2026-04-28 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.uhrit.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.